Furthermore, while oligonol may alleviate DMN-induced liver fibrosis by inhibiting p53-mediated apoptosis, there is a potential risk that it could amplify the likelihood of liver cancer if it overly suppresses the p53 pathway. Here, TP53 is linked to liver cancer.